Bill Text: FL S0612 | 2023 | Regular Session | Enrolled

---

Bill Title: Blood Clot and Pulmonary Embolism Policy Workgroup

Spectrum: Slight Partisan Bill (Republican 28-12-1)

Status: (Passed) 2023-06-06 - Chapter No. 2023-192 [S0612 Detail]

Download: Florida-2023-S0612-Enrolled.html

---

       ENROLLED
       2023 Legislature                                   CS for SB 612
       
       
       
       
       
       
                                                              2023612er
    1  
    2         An act relating to the blood clot and pulmonary
    3         embolism policy workgroup; providing a short title;
    4         creating s. 408.0621, F.S.; requiring the Secretary of
    5         Health Care Administration, in conjunction with the
    6         State Surgeon General, to establish a blood clot and
    7         pulmonary embolism policy workgroup; providing for the
    8         duties, membership, and meetings of the workgroup;
    9         requiring the secretary to submit annual reports to
   10         the Governor and the Legislature; requiring the
   11         secretary to submit a final report to the Governor and
   12         the Legislature by a specified date; providing an
   13         effective date.
   14          
   15  Be It Enacted by the Legislature of the State of Florida:
   16  
   17         Section 1. This act may be cited as the “Emily Adkins
   18  Prevention Act.”
   19         Section 2. Section 408.0621, Florida Statutes, is created
   20  to read:
   21         408.0621 Blood clot and pulmonary embolism policy
   22  workgroup.—
   23         (1) The Secretary of Health Care Administration, in
   24  conjunction with the State Surgeon General, shall establish a
   25  blood clot and pulmonary embolism policy workgroup.
   26         (2) The workgroup shall:
   27         (a) Identify the aggregate number of people who experience
   28  blood clots and pulmonary embolisms each year in this state.
   29         (b) Identify how data is collected regarding blood clots,
   30  pulmonary embolisms, and adverse health outcomes associated with
   31  these conditions.
   32         (c) Identify how blood clots and pulmonary embolisms impact
   33  the lives of people in this state.
   34         (d) Identify the standards of care for blood clot
   35  surveillance, detection, and treatment.
   36         (e) Identify emerging treatments, therapies, and research
   37  relating to blood clots.
   38         (f) Develop a risk surveillance system to help health care
   39  providers identify patients who may be at a higher risk of
   40  forming blood clots and pulmonary embolisms.
   41         (g) Develop policy recommendations to help improve patient
   42  awareness of blood clot risks.
   43         (h) Develop policy recommendations to help improve
   44  surveillance and detection of patients who may be at a higher
   45  risk of forming blood clots in licensed health care facilities,
   46  including, hospitals, nursing homes, assisted living facilities,
   47  residential treatment facilities, and ambulatory surgical
   48  centers.
   49         (i) Develop policy recommendations relating to guidelines
   50  used that affect the standard of care for patients at risk of
   51  forming blood clots.
   52         (j) Develop policy recommendations relating to providing
   53  patients and their families with written notice of increased
   54  risks of forming blood clots.
   55         (3)(a) The workgroup shall be composed of health care
   56  providers, patients who have experienced blood clots, family
   57  members of patients who have died from blood clots, advocates,
   58  and other interested parties and associations.
   59         (b) The President of the Senate and the Speaker of the
   60  House of Representatives shall each appoint two members to the
   61  workgroup.
   62         (c) Members of the workgroup shall serve without
   63  compensation.
   64         (d) The State Surgeon General shall appoint the chair of
   65  the workgroup.
   66         (e) The chair is authorized to create subcommittees to help
   67  with research, scheduling speakers on important subjects, and
   68  drafting a workgroup report and policy recommendations.
   69         (f) Meetings of the workgroup may be held through
   70  teleconference or other electronic means.
   71         (4)(a) The Secretary of Health Care Administration shall
   72  submit an annual report detailing his or her findings and
   73  recommendations to the Governor, the President of the Senate,
   74  and the Speaker of the House of Representatives.
   75         (b) The Secretary of Health Care Administration shall
   76  submit a final report detailing his or her findings and
   77  recommendations to the Governor, the President of the Senate,
   78  and the Speaker of the House of Representatives by January 4,
   79  2025.
   80         Section 3. This act shall take effect July 1, 2023.